Amalgamated Bank Adicet Bio, Inc. Transaction History

Amalgamated Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$1.76 - $3.45 $3,118 - $6,113	-1,772 Reduced 64.13%	991 $2,000
Q4 2023 Feb 06, 2024	SELL	$1.11 - $1.89 $327 - $557	-295 Reduced 9.65%	2,763 $5,000
Q1 2023 May 02, 2023	SELL	$5.52 - $9.23 $4,388 - $7,337	-795 Reduced 20.63%	3,058 $18,000
Q4 2022 Feb 10, 2023	BUY	$7.72 - $21.27 $1,984 - $5,466	257 Added 7.15%	3,853 $34,000
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $10,947 - $22,204	1,067 Added 42.19%	3,596 $53,000
Q1 2022 Jun 30, 2022	BUY	$11.53 - $19.97 $29,159 - $50,504	2,529 New	2,529 $51,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $39.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.